Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuwei Wang

Showing results (621-630 of 637) with videos related to

Pageof 64
Sort By:
Light, Science & Applications|February 14, 2024
Wearable and interactive multicolored photochromic fiber displayPan Li, Yuwei Wang, Xiaoxian He, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2024
A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis-directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal CarcinomaXin Zhang, Jin Yan, Qianqian Lei, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancerYuwei Wang, Annegien Broeks, Daniele Giardiello, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
The Lancet. Digital Health|December 11, 2025
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancerYoni Schirris, Rosie Voorthuis, Mark Opdam, et al.
Molecular Cancer Therapeutics|January 19, 2012
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor targetColin C Collins, Stanislav V Volik, Anna V Lapuk, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
Gut|May 19, 2021
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapyJumin Huang, Di Liu, Yuwei Wang, et al.
Oral Oncology|July 2, 2026
Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & IrelandJohn Gaffney, Anna France, Romelie Rieu, et al.
Pageof 64

Showing results (621-630 of 637) with videos related to

Sort By:
Pageof 64
Light, Science & Applications|February 14, 2024
Wearable and interactive multicolored photochromic fiber displayPan Li, Yuwei Wang, Xiaoxian He, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2024
A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis-directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal CarcinomaXin Zhang, Jin Yan, Qianqian Lei, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancerYuwei Wang, Annegien Broeks, Daniele Giardiello, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
The Lancet. Digital Health|December 11, 2025
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancerYoni Schirris, Rosie Voorthuis, Mark Opdam, et al.
Molecular Cancer Therapeutics|January 19, 2012
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor targetColin C Collins, Stanislav V Volik, Anna V Lapuk, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
Gut|May 19, 2021
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapyJumin Huang, Di Liu, Yuwei Wang, et al.
Oral Oncology|July 2, 2026
Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & IrelandJohn Gaffney, Anna France, Romelie Rieu, et al.
Pageof 64